转移
脂肪肝
癌症研究
肿瘤微环境
日历年61
肝细胞
生物
癌症
医学
病理
内科学
生长因子
生物化学
疾病
CTGF公司
受体
肿瘤细胞
体外
作者
Zhijun Wang,So Yeon Kim,Wei Tu,Ji‐Eun Kim,Alexander M. Xu,Yoon Mee Yang,Michitaka Matsuda,Lien Reolizo,Takashi Tsuchiya,Sandrine Billet,Alexandra Gangi,Mazen Noureddin,Ben Falk,Sung‐Jin Kim,Wei Fan,Mourad Tighiouart,Sungyong You,Michael Lewis,Stephen J. Pandol,Dolores Di Vizio
出处
期刊:Cell Metabolism
[Cell Press]
日期:2023-05-11
卷期号:35 (7): 1209-1226.e13
被引量:98
标识
DOI:10.1016/j.cmet.2023.04.013
摘要
Summary
Liver metastasis is a major cause of death in patients with colorectal cancer (CRC). Fatty liver promotes liver metastasis, but the underlying mechanism remains unclear. We demonstrated that hepatocyte-derived extracellular vesicles (EVs) in fatty liver enhanced the progression of CRC liver metastasis by promoting oncogenic Yes-associated protein (YAP) signaling and an immunosuppressive microenvironment. Fatty liver upregulated Rab27a expression, which facilitated EV production from hepatocytes. In the liver, these EVs transferred YAP signaling-regulating microRNAs to cancer cells to augment YAP activity by suppressing LATS2. Increased YAP activity in CRC liver metastasis with fatty liver promoted cancer cell growth and an immunosuppressive microenvironment by M2 macrophage infiltration through CYR61 production. Patients with CRC liver metastasis and fatty liver had elevated nuclear YAP expression, CYR61 expression, and M2 macrophage infiltration. Our data indicate that fatty liver-induced EV-microRNAs, YAP signaling, and an immunosuppressive microenvironment promote the growth of CRC liver metastasis.
科研通智能强力驱动
Strongly Powered by AbleSci AI